Mark Purcell
Stock Analyst at Morgan Stanley
(0)
# 4447
Out of 5,370 analysts
5
Total ratings
50.00%
Success rate
-10.13%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NVS Novartis | Initiates Coverage On: Equal-Weight | 114 | 118.11 | -3.48% | 1 | Jan 23, 2024 | |
SNY Sanofi | Initiates Coverage On: Equal-Weight | 55 | 49.38 | 11.38% | 1 | Jan 23, 2024 | |
GSK GSK | Initiates Coverage On: Equal-Weight | 44 | 40.48 | 8.7% | 1 | Jan 23, 2024 | |
AZN AstraZeneca | Initiates Coverage On: Overweight | 85 | 73.48 | 15.68% | 1 | Jan 23, 2024 | |
NVO Novo Nordisk | Initiates Coverage On: Overweight | 120 | 76.93 | 55.99% | 1 | Jan 23, 2024 |